Morphologic Investigation of the West Branch of the Susquehanna River in North-central Pennsylvania

Author(s):  
J. Newlin ◽  
B. Hayes ◽  
K. Yee
1994 ◽  
Vol 42 (2) ◽  
pp. 131-135 ◽  
Author(s):  
Thomas W. Gardner ◽  
Ira D. Sasowsky ◽  
Victor A. Schmidt

AbstractA new exposure of glacial and glaciolacustrine sediments at Antes Fort allows for revision of the chronology of pre-Wisconsinan glaciation in central Pennsylvania. Lacustrine sediments from a proglacial lake in the West Branch Susquehanna River valley have reversed remanent polarity with a site mean paleomagnetic declination of 193.8° and inclination of -13.1°. The magnetization is probably a true detrital remanence from the time of deposition and is not significantly affected by postdepositional diagenesis. We propose that the Antes Fort till was deposited during either pre-Illinoian glaciation F or G of G. M. Richmond and D. S. Fullerton (1986, "Quaternary Science Reviews," Vol. 5, 183-196) between 770,000 and 970,000 yr ago. We suggest that it is equivalent to the Penny Hill till in the West Branch Susquehanna River valley and tentatively correlate it westward with the reversed polarity terrace deposits and Minford Silt in western Pennsylvania, West Virginia, and Ohio; the West Lebanon till in Indiana; and the A4 tills (or possible B tills) in Iowa and Nebraska.


2020 ◽  
Author(s):  
Robert Q. Oaks ◽  
◽  
Susanne U. Janecke ◽  
Tammy M. Rittenour ◽  
Thad L. Erickson ◽  
...  

Circulation ◽  
2018 ◽  
Vol 137 (suppl_1) ◽  
Author(s):  
Inmaculada Hernandez ◽  
Samir Saba ◽  
Yuting Zhang

Background: Recent studies have shown strong geographic variation in oral anticoagulation (OAC) use in atrial fibrillation (AF); however, it remains unknown how this contributes to the geographic variation in ischemic stroke observed across the US. The objective of the present study was to evaluate the relationship between the geographic variation in the initiation of OAC and the incidence of ischemic stroke in a cohort of Medicare beneficiaries newly diagnosed with AF. Methods: Using 2013-2014 claims data from a 5% random sample of Medicare beneficiaries, we identified patients newly diagnosed with AF in 2013-2014 and categorized them according to their initiation of OAC. Our sample included 21,226 OAC initiators and 20,068 patients who did not initiate OAC therapy. We assigned each patient to one of the 9 US Census Divisions using the zip code, and collected their medical claims with a diagnosis of ischemic stroke. We constructed logistic regression models to estimate the average adjusted probability of OAC initiation and Poisson models to estimate the average adjusted rate of ischemic stroke, in each Census Division. Both estimates were adjusted for demographics, eligibility for Medicaid coverage and for low-income subsidy, enrollment in a Medicare Advantage Part D plan, and a comprehensive list of clinical characteristics. We computed the correlation between the average adjusted probability of OAC initiation and the average adjusted rate of ischemic stroke at the Census Division level. Results: The probability of OAC initiation was lowest in the West South Central (0.47) and highest in the West North Central (0.54) and New England (0.54). The average adjusted rate of ischemic stroke was lowest in the West North Central (0.09) and highest in the South Atlantic (0.14) and South West Central (0.14). The average adjusted probability of OAC initiation at the Census Division level and the average adjusted rate of ischemic stroke were inversely correlated, with R=-0.576, p-value=0.10. This suggests that variation in OAC initiation likely explains at least a third of geographic variation in ischemic stroke [R 2 =(-0.576) 2 =0.332]. Conclusions: Our results suggest that geographic variations in OAC initiation within the U.S. explain, in part, variations in the incidence of ischemic stroke among AF patients. Further mechanistic research using advanced causal mediation models is warranted.


PEDIATRICS ◽  
1948 ◽  
Vol 2 (1) ◽  
pp. 138-140

THE accompanying table summarizes the incidence of nine important communicable diseases, based on weekly telegraphic reports from State health departments. The reports from each State for each week are published in PUBLIC HEALTH REPORTS under the section "Incidence of Disease." [See Table in Source Pdf]. Diseases Above Median Incidence Measles—The number of cases of measles rose from 102,680 during the preceding 4 weeks to 114,983 during the 4 weeks ended May 22. The incidence was 3.4 times the number of cases reported for the corresponding period in 1947, which was, however, a comparatively low measles year, but it was only about 10 percent above the 1943-47 median. In the New England and East South Central sections the incidence was below the normal expectancy and in the South Atlantic section the number of cases was only slightly higher than the median for the preceding 5 years, but in the other 6 sections the increases over the median expectancy ranged from 1.1 times the median in the West North Central section to 3.4 times the median in the West South Central section. Poliomyelitis.— The number of cases of poliomyelitis rose from 126 during the preceding 4-week period to 440 during the current 4 weeks. The incidence was 3.5 times that reported for these weeks in 1947, which number (126 cases) also represents the 1943-47 median. An increase of this disease is expected at this season of the year, but the current number of cases represents a larger increase at this time than has normally occurred in preceding years. While each section of the country except New England contributed to the relatively high incidence, the greatest excesses over the 5-year medians were reported from the West North Central and West South Central sections. Of the total cases Texas reported 179, California 62, South Carolina 46, New Jersey 16, Iowa 14, Florida 12, Alabama 11, and Illinois, South Dakota, and Louisiana 10 each; 85 percent of the reported cases occurred in those 10 states which represent every section of the country except the New England and Mountain sections. Since the beginning of the year there have been 947 cases of poliomyelitis reported as compared with 894 and 810 for the corresponding period in 1947 and 1946, respectively.


Plant Disease ◽  
2012 ◽  
Vol 96 (1) ◽  
pp. 147-147 ◽  
Author(s):  
G. W. Moorman ◽  
A.-S. Walker ◽  
S. May

Greenhouse-grown Heuchera plants, treated with fenhexamid (Decree, SePRO, Carmel, IN; FRAC group 17 hydroxyanilide), with active gray mold were submitted to the Penn State Plant Disease Clinic in December 2010 from a commercial operation in north-central Pennsylvania. Genetic and phenotypic analyses identified the isolate as Botrytis cinerea Pers. (teleomorph Botryotinia fuckeliana (de Bary) Whetzel), HydR3 phenotype (2) and not B. pseudocinerea (previously Botrytis group I) (4), naturally resistant to fenhexamid (phenotype HydR1) (1). While 0.2 μg of fenhexamid per ml or less is required to slow mycelial growth and germ tube elongation of sensitive isolates by 50% (EC50), the radial growth EC50 of the Heuchera isolate was approximately 2,000 μg of fenhexamid per ml in culture. Five cucumber seedlings receiving 25 μl of 0.1 M dextrose containing the label rate of Decree (1,800 μg/ml) on the growing tip were inoculated with colonized agar in the drop. Five check plants received 25 μl of 0.1 M dextrose. B. cinerea from silica gel storage since 1988 was also tested. This experiment was repeated three times. The 1988 isolate killed all fungicide-free but no fenhexamid-treated plants. The Heuchera isolate killed all fungicide-free and fenhexamid-treated plants within 4 days. To our knowledge, this is the first report of B. cinerea from a greenhouse in North America with fenhexamid resistance. Resistance occurs in U.S. fields (3). The Heuchera isolate's HydR3 resistance phenotype (2) has been detected in Germany, Japan, and France and has mutations affecting the 3-keto reductase protein, encoded by the erg27 gene, the specific target of fenhexamid and involved in Botrytis sterol biosynthesis. The Decree label states that it is to be used only twice on a crop before switching to a different mode of action. Greenhouses have resident Botrytis populations that are likely to be exposed to any fungicide applied in the structure. Growers should consider using fenhexamid only twice in a particular greenhouse, rather than on a particular crop, before switching to a different mode of action. References: (1) P. Leroux et al. Crop Prot. 18:687, 1999.(2) P. Leroux et al. Pest Manag. Sci. 58:876, 2002. (3) Z. Ma and T. J. Michailides. Plant Dis. 89:1083, 2005. (4) A.-S. Walker et al. Phytopathology 101:1433, 2011.


Sign in / Sign up

Export Citation Format

Share Document